SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Operating Segment (Details) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
segment
|
Jun. 30, 2025
USD ($)
|
|
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||||
| Number of reportable segments | segment | 1 | |||
| Number of operating segments | segment | 1 | |||
| Total research and development expenses | $ 3,627,168 | $ 2,050,585 | $ 7,060,930 | $ 4,424,724 |
| Single reportable segment | ||||
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||||
| External clinical development expenses | 2,475,836 | 1,637,683 | 4,959,301 | 3,334,914 |
| Personnel related and stock-based compensation | 1,027,495 | 258,072 | 1,749,752 | 687,490 |
| Other research and development expenses | 123,837 | 154,830 | 351,877 | 402,320 |
| Total research and development expenses | $ 3,627,168 | $ 2,050,585 | $ 7,060,930 | $ 4,424,724 |
| X | ||||||||||
- Definition Amount of expense for research and development pursuant to external clinical development. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development pursuant to personnel related and stock-based compensation. No definition available.
|
| X | ||||||||||
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|